Long-acting muscarinic antagonist use in adults with asthma: Real-life prescribing and outcomes of add-on therapy with tiotropium bromide

Journal of Asthma and Allergy

Volumn 8, Issue , 2015, Pages

  Price, David ^a,b   Kaplan, Alan ^c   Jones, Rupert ^d   Freeman, Daryl ^e   Burden, Anne ^b   Gould, Shuna ^b   von Ziegenweidt, Julie ^b   Ali, Muzammil ^b   King, Christine ^b   Thomas, Mike ^f  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Research in Real Life   (United Kingdom)

^c Family Physician Airways Group of Canada   (Canada)

^d UNIVERSITY OF PLYMOUTH   (United Kingdom)

^e NORFOLK COMMUNITY HEALTH AND CARE NHS TRUST   (United Kingdom)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Anticholinergic; Asthma control; Bronchodilator; Exacerbation; Oral corticosteroids

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; SALBUTAMOL; TIOTROPIUM BROMIDE;

ADD ON THERAPY; ADULT; ARTICLE; ASTHMA; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LOWER RESPIRATORY TRACT INFECTION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SMOKING; TREATMENT OUTCOME;

EID: 84921522801     PISSN: None     EISSN: 11786965     Source Type: Journal    
DOI: 10.2147/JAA.S76639     Document Type: Article

References (20)

1. Price D, Fromer L, Kaplan A, van der Molen T, Román-Rodríguez M. Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma? NPJ Prim Care Respir Med. 2014;24:14023.
2. Kerstjens HA, Disse B, Schröder-Babo W, et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J Allergy Clin Immunol. 2011;128:308-314.
3. Kerstjens HA, Engel M, Dahl R, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med. 2012;367: 1198-1207.
4. Wilson J, Bateman ED, Pavord I, Lloyd A, Krivasi T, Esser D. Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonists. Appl Health Econ Health Policy. 2014;12:447-459.
5. Kapoor AS, Olsen SR, O'Hara C, Puttagunta L, Vethanayagam D. The efficacy of tiotropium as a steroid-sparing agent in severe asthma. Can Respir J. 2009;16:99-101.
6. Adams KS, Lowe DK. Tiotropium for adults with inadequately controlled persistent asthma. Ann Pharmacother. 2013;47:117-123.
7. Hyland ME, Whalley B, Jones RC, Masoli M. A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scales. Qual Life Res. September 9, 2014. [Epub ahead of print.]
8. Summary of Product Characteristics. Spiriva Respimat 2.5 micrograms solution for inhalation. Electronic Medicines Compendium. Available from: http://www.medicines.org.uk/emc/medicine/20134. Accessed October 13, 2014.
9. Fardon T, Haggart K, Lee DK, Lipworth BJ. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Respir Med. 2007;101:1218-1228.
10. Bateman ED, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri LM. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol. 2011;128:315-322.
11. Beeh KM, Moroni-Zentgraf P, Ablinger O, et al. Tiotropium Respimat® in asthma: a double-blind, randomised, dose-ranging study in adult asthma patients with moderate asthma. Respir Res. 2014;15:61.
12. Vogelberg C, Engel M, Moroni-Zentgraf P, et al. Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomised dose-ranging study. Respir Med. 2014;108:1268-1276.
13. Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med. 2010;363:1715-1726.
14. Roche N, Reddel HK, Agusti A, et al. Integrating real-life studies in the global therapeutic research framework. Lancet Respir Med. 2013;1:e29-e30.
15. Summary of Product Characteristics. Spiriva 18 microgram inhalation powder. Electronic Medicines Compendium. Available from: http://www.medicines.org.uk/emc/medicine/10039. Accessed October 13, 2014.
16. Hohlfeld JM, Sharma A, van Noord JA, et al. Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease. J Clin Pharmacol. 2014;54: 405-414.
17. Mathioudakis AG, Chatzimavridou-Grigoriadou V, Evangelopoulou E, Mathioudakis GA, Siafakas NM. Comparative mortality risk of tiotropium administered via Handihaler or Respimat in COPD patients: are they equivalent? Pulm Pharmacol Ther. 2014;28:91-97.
18. Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations. Am J Respir Crit Care Med. 2009;180: 59-59.
19. British Thoracic Society. SIGN 141. British guideline on the management of asthma. London, UK: 2014. Available from: https://www.brit-thoracic.org.uk/document-library/clinical-information/asthma/btssign-asthma-guideline-2014/. Accessed October 13, 2014.
20. Sims EJ, Price D, Haughney J, Ryan D, Thomas M. Current control and future risk in asthma management. Allergy Asthma Immunol Res. 2011;3:217-225.